Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cesamet for Pain in Multiple Sclerosis
NCT00381264Phase 4Completed
- Sponsor
- NEMA Research
- Start
- Sep 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nabilone in multiple sclerosis (MS), sponsored by NEMA Research. Primary endpoint: Average Pain Score at target site. Started Sep 2006; status: completed.
02
Drugs
nabilone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00381264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381264.